Viewing Study NCT00576056

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:17 PM
Ignite Modification Date: 2026-02-22 @ 7:03 AM
Study NCT ID: NCT00576056
Status: TERMINATED
Last Update Posted: 2017-02-15
First Post: 2007-12-14
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Effectiveness and Safety Study of TACE Plus Oral Sorafenib for Unresectable HCC
Sponsor: University of Pittsburgh
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Carcinoma, Hepatocellular View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Hepatocellular View
None Carcinoma View
None TACE View
None Sorafenib View
None Transcatheter Arterial Chemoembolization View
None Nexavar View
None Unresectable View